Executives close to this deal say there were, early on, several bidders for American Home Products Corp. 's medical device businesses—including European device companies such as B. Braun Melsingun AGand Smiths Industries PLC , as well as some investors who saw the acquisition as purely a financial play. But in the end, the deal really belonged to Kendall Company, which hopes, with the addition of Sherwood-Davis & Geck , to create a product offering to rival its principal competitor, Johnson & Johnson .
The conventional wisdom on the deal is that AHP's divestiture of SD&G is further evidence that drug companies are getting tired of their medical device businesses. And that certainly seems...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?